DKK 3.98
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | 7.21 Million | 6.85 Million | 4.23 Million | - | - |
Net Income | -9.31 Million | -21.64 Million | -17.82 Million | -1.98 Million | 69.72 Thousand | 8770.00 |
Depreciation & Amortization | - | 3.6 Million | 3.42 Million | 2.11 Million | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | 9.31 Million | 21.64 Million | 17.82 Million | 1.98 Million | -69.72 Thousand | -8770.00 |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | 3.73 Million | 12.18 Thousand | 959.01 Thousand | 899.41 Thousand | - |
Cash at end of period | - | 453 Thousand | 3.73 Million | 12.18 Thousand | 959.01 Thousand | - |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | -3.28 Million | 3.72 Million | -946.82 Thousand | 59.59 Thousand | - |
Free Cash Flow | - | 7.21 Million | 6.85 Million | 4.23 Million | - | - |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -12.19 Million | -2.58 Million | -2.58 Million | -9.31 Million | -519 Thousand | -2.5 Million |
Depreciation & Amortization | 946 Thousand | 949.5 Thousand | 949.5 Thousand | - | - | 948 Thousand |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | 8.26 Million | -90.5 Thousand | -90.5 Thousand | 9.31 Million | 519 Thousand | -3.66 Million |
Investing Cash Flow | -233 Thousand | -233 Thousand | -233 Thousand | - | - | -141 Thousand |
Investments in PPE | -233 Thousand | - | - | - | - | -141 Thousand |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | -233 Thousand | -233 Thousand | - | - | -141 Thousand |
Financing Cash Flow | 3.33 Million | 2.03 Million | 2.03 Million | - | - | 4.23 Million |
Debt repayment | -1.03 Million | - | - | - | - | -7.11 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 2.3 Million | - | - | - | - | 11.34 Million |
Other Financing Activities | -1000.00 | 2.03 Million | 2.03 Million | - | - | 4.23 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | - | - | 134 Thousand | 377 Thousand |
Cash at end of period | 117 Thousand | 80.5 Thousand | 80.5 Thousand | - | 134 Thousand | 134 Thousand |
Capital Expenditure | -233 Thousand | - | - | - | - | -141 Thousand |
Effect of forex changes on cash | - | - | - | - | - | 893 Thousand |
Net cash flow / Change in cash | 117 Thousand | 80.5 Thousand | 80.5 Thousand | - | - | -243 Thousand |
Free Cash Flow | -3.21 Million | -1.72 Million | -1.72 Million | - | - | -5.36 Million |
INVP
RLO
LOVABLE
SURANASOL
SUNDRMFAST
TIFA